Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival

Cancer

Volumn 119, Issue 10, 2013, Pages 1900-1907

  Hu, Chung Yuan ^a   Xing, Yan ^a   Cormier, Janice N ^a   Chang, George J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

cancer; cancer specific survival; cause of death; End Results; Epidemiology; relative survival; Surveillance

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CAUSE OF DEATH; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIPLE CANCER; ONSET AGE; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CAUSE OF DEATH; COLORECTAL NEOPLASMS; DEATH CERTIFICATES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; SEER PROGRAM; SKIN NEOPLASMS; SURVIVAL RATE; UNITED STATES;

EID: 84877582672     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27968     Document Type: Article

References (15)

1. Hoel DG, Ron E, Carter R, Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst. 1993;85:1063-1068.
2. Smith Sehdev AE, Hutchins GM. Problems with proper completion and accuracy of the cause-of-death statement. Arch Intern Med. 2001;161:277-284.
3. Flanders WD. Inaccuracies of death certificate information. Epidemiology. 1992;3:3-5.
4. Begg CB, Schrag D. Attribution of deaths following cancer treatment. J Natl Cancer Inst. 2002;94:1044-1045.
5. Percy C, Stanek E 3rd, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health. 1981;71:242-250.
6. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961;6:101-121.
7. Chiang CL. A stochastic study of the life table and its applications. II. Sample variance of the observed expectation of life and other biometric functions. Hum Biol. 1960;32:221-238.
8. Gittelsohn A, Royston PN. Annotated bibliography of cause-ofdeath validation studies. Vital Health Stat 2. 1982;89:1-42.
9. Weinstock MA, Reynes JF. Validation of cause-of-death certification for outpatient cancers: the contrasting cases of melanoma and mycosis fungoides. Am J Epidemiol. 1998;148:1184-1186.
10. Best WR, Cowper DC. The ratio of observed-to-expected mortality as a quality of care indicator in non-surgical VA patients. Med Care. 1994;32:390-400.
11. Greene FL, Page DL, Fleming ID, et al. eds. AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag; 2002.
12. Bernard R. Fundamentals of Biostatistics, 6th ed. Pacific Grove, CA: Duxbury Press; 2005.
13. Sarfati D, Blakely T, Pearce N. Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol. 2010;39:598-610.
14. Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. J Clin Oncol. 2009;27:5938-5943.
15. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Program research data (1973-2007). Released April 2010, based on the November 2009 submission. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2010.